ImmunoGen Stock Price (NASDAQ:IMGN)

Add to My Stocks
$11.19 $0.33 (3.04%) IMGN stock closing price Feb 23, 2018 (Closing)
Prev Close* : $10.86
Market Cap:
$1.48B
Day Low: $10.77
52 Week Low: $2.43
Open: $10.92
Volume: -
Day High: $11.4
52 Week High: $12.05
Dividend:
0.00

Latest Stock Market News

Latest Articles

ImmunoGen News - From Partners

IMGN Stockcharts

View IMGN PE ratio, PS ratio stocks charts and compare with peers.
IMGN Chart
Note: Compare ImmunoGen stock price history with the index and industry peers.

ImmunoGen Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
12.06
PB ratio (
price to book ratio
)
-999.0000

ImmunoGen Returns

ROE
(return on equity)
-

ImmunoGen Financial Ratios

Asset Turnover
-
Receivables Turnover
-
Debt to Equity
-
Dividend Yield
0%

IMGN Industry Peers

Company Price Change (%)
Endo International (ENDP)6.860.3 (4.57%)
Zogenix (ZGNX)43.450.25 (0.58%)
Takeda Pharma (TKPYY)28.090.45 (1.63%)
Amgen (AMGN)186.674.22 (2.31%)
Seattle Genetics (SGEN)55.351.57 (2.92%)
Novartis (NVS)85.330.13 (0.15%)
Sanofi (SNY)40.130.28 (0.7%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Spectrum Pharma (SPPI)22.492.03 (9.92%)
TherapeuticsMD (TXMD)5.370.36 (7.19%)
Xencor (XNCR)27.641.25 (4.74%)
Arrowhead Pharma (ARWR)5.80.26 (4.69%)
BioCryst Pharma (BCRX)5.020.22 (4.58%)
Endo International (ENDP)6.860.3 (4.57%)
Endocyte (ECYT)3.890.17 (4.57%)
Top gainers from Medical-Drugs industry
* As of Feb 24, 2018
CompanyPriceChange (%)
ChemoCentryx (CCXI)9.560.71 (6.91%)
ACER THERAPEUTS (ACER)17.280.88 (4.85%)
Lannett Co (LCI)15.850.7 (4.23%)
Regulus Therapeutics (RGLS)1.160.04 (3.33%)
Enanta Pharma (ENTA)77.471.94 (2.44%)
BioLineRx (BLRX)0.9890.02 (1.98%)
Cumberland Pharma (CPIX)6.720.13 (1.9%)
Top losers from Medical-Drugs industry
* As of Feb 24, 2018

ImmunoGen, Inc. Stock News - Partner Headlines

ImmunoGen Financial Statements

income statement20162015201420132012
Net Sales or Revenues60M18.02M48.3M30.06M2.61M
Net Income-143.66M-33.22M13.63M3.81M-24.39M
Total Operating Expense046.24M34.51M26.3M27.11M
View ImmunoGen income statement
balance sheet20152014201320122011
Total Assets251.58M128.54M202.52M230.83M208.21M
Total Liabilities268.26M51.07M72.48M94.84M92.87M
Shareholders Equity-16.68M77.47M130.03M135.99M115.34M
View ImmunoGen balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) in Assets Liabilities-9.55M-37.77M-25.05M-1.58M-
Net Cash from (used by) Operating Activities-65.49M-34.38M-21.62M-42.7M-24.03M
Increase (Decrease) in Prop Plant And Equipment-5.12M-2.59M-2.29M-2.03M-0.83M
View ImmunoGen cash flow statement

ImmunoGen Stock Message Board

As of last trading day, ImmunoGen stock price was $11.19. ImmunoGen market capitalization is $1.48B and it represents the total market value of IMGN stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing ImmunoGen stock analysis.

For recognizing and analyzing the real performance of ImmunoGen stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 2,654,625 on the last trading day, as is evident from ImmunoGen stock chart, and IMGN stock quote data. ImmunoGen paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of IMGN, view ImmunoGen stock price history.